Alex Hamilton, based in London, GB, is currently a Chief Financial Officer at Re-Aim Therapeutics. Alex Hamilton brings experience from previous roles at Syncona Limited, Spur Therapeutics, ANAVEON AG and SwanBio Therapeutics. Alex Hamilton holds a 2009 - 2012 Doctor of Philosophy (PhD) in T Cell Immunology @ Cambridge University. With a robust skill set that includes Portfolio Management, Public Speaking, Business Strategy, Analysis, Microsoft Word and more. Alex Hamilton has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Alex Hamilton?
Find contact details for 700 million professionals.